Health Care/Hospital

CStone Announces the NDA Approval of GAVRETO® (pralsetinib) for the Treatment of RET Fusion-Positive treatment-naïve (first-line) and pretreated Non-Small Cell Lung Cancer (NSCLC) in Hong Kong, China

* GAVRETO is the first highly selective rearranged during transfection (RET) inhibitor approved inHong Kong, China for the treatment of RET fusion-positive metastatic non-small cell lung cancer * GAVRETO is CStone's second therapy approved in Hong Kong, China * GAVRETO is CStone's ninth NDA ...

2022-07-15 08:02 3187

Zymo Research's DNA/RNA Shield™ Inactivates Monkeypox for the Collection and Transportation of Samples

IRVINE, Calif., July 15, 2022 /PRNewswire/ -- Zymo Research Corp., in collaboration with the Institute of Virology, University Medical Center Freiburg,Germany, demonstrated data showing their DNA/RNA Shield™ Inactivating Transport Medium (ITM) completely inactivated recent Monkeypox virus isolate...

2022-07-15 06:42 3020

Nefertiti Greene Joins Mars Petcare to Run New Science & Diagnostics Division

* Mars Petcare announces former Johnson & Johnson executive Nefertiti Greene as member of Global Petcare Leadership team * Greene will head new division within Mars Petcare, Science & Diagnostics  * Demonstrates company's deep commitment to advancing science and innovation  BRUSSELS, July 14...

2022-07-14 21:38 2684

Merck Launches its Uptune Program in Asia for Collaborating with Startups

* Application period for the Merck Uptune program starts today * Topics vary from AI-enabled health and cell and gene therapy tools to innovative technologies and materials in semiconductor and smart manufacturing * Selected startups can receive funding of up to € 100,000 SHANGHAI, July 14, ...

2022-07-14 20:16 5835

Urgent support needed following the pandemic's effect on cancer screening services

Dry July call to arms will improve support for cancer patients SYDNEY, July 14, 2022 /PRNewswire/ -- Dry July Foundation is urging Australians to dig even deeper this Dry July to help people affected by cancer. So many Australians could not access vital lifesaving cancer screenings and treatment...

2022-07-14 17:19 2604

Tianlong launched a campaign to care for SMA children

XI'AN China, July 14, 2022 /PRNewswire/ -- Tianlong has launched a campaign together with the Spinal muscular atrophy (SMA) care center inChina (a non-profit organization for SMA), and The Second Affiliated Hospital of Xi'an Jiaotong University to care for children with SMA inMay 2022. Spinal mu...

2022-07-14 16:08 2556

Oncoshot Receives Funding To Expand Cancer Data Sharing Capabilities For Hospitals and Industry

SINGAPORE, July 14, 2022 /PRNewswire/ -- Oncoshot today announced a pre-series A funding round led by MassMutual Ventures (MMV). Other investors for this stage come from a suite of healthtech veterans that include Milltrust International and health industry angel investors.  This funding wi...

2022-07-14 15:30 2325

Nanoform and Pharmanovia to breathe new life into iconic medicines

HELSINKI, July 14, 2022 /PRNewswire/ -- Nanoform Finland Plc., an innovative nanoparticle medicine-enabling company, today announced that it has partnered with Pharmanovia, a fast-growing specialty pharma business with a portfolio of over 20 branded drugs in 140 markets. The new strategic partne...

2022-07-14 13:55 1530

GenScript ProBio and DAAN Bio Therapeutics, Sign a Strategic Cooperation MOU for the Discovery and Development of Novel Drugs

SEOUL, South Korea, July 14, 2022 /PRNewswire/ -- On the July 14, 2022, GenScript ProBio (Brian Ho-sung Min, CEO), a global CDMO, and DAAN Bio Therapeutics (Byoung Chul Cho, Co-Founder & CEO), an innovative new drug developer such as antibody treatments and cell therapy drugs, announced that the...

2022-07-14 13:00 2105

Triastek announces research collaboration with Lilly to explore the application of 3D printing technology in oral delivery of drugs

NANJING, China, July 14, 2022 /PRNewswire/ -- On July 13, 2022, Triastek, Inc. ("Triastek") announced a collaboration with Eli Lilly and Company ("Lilly"), a leading global pharmaceutical company, to leverage the advantages of 3D printing technology to enable precisely targeted and programmed rel...

2022-07-14 09:00 2531

U.S. FDA Grants Emergency Use Authorization for Novavax COVID-19 Vaccine, Adjuvanted for Individuals Aged 18 and Over

* Novavax' vaccine is the first protein-based COVID-19 vaccine authorized in the U.S. * Immunizations with the Novavax COVID-19 Vaccine, Adjuvanted as a primary series will begin upon product release and once a policy recommendation from the CDC is received GAITHERSBURG, Md., July 14, 2022 /P...

2022-07-14 06:06 2444

miR Scientific is proud to announce the commercial availability of the miR Sentinel™ Prostate Cancer Test

NEW YORK, July 14, 2022 /PRNewswire/ -- miR Scientific, LLC announces the miR Sentinel™ Prostate Cancer Test is now commercially available in the United States, Puerto Rico and select international markets.  miR Sentinel™ is a novel, urine-based, molecular test that analyzes small non-coding RNA ...

2022-07-14 00:20 2107

Filling gap in market: VenusP-Valve™ approved by China's NMPA

HANGZHOU, China, July 13, 2022 /PRNewswire/ -- On July 11, 2022, VenusP-ValveTM , Venus Medtech's in-house developed innovative transcatheter pulmonic valve replacement (TPVR) system, was approved byChina's National Medical Products Administration (NMPA) for the treatment of severe pulmonary regur...

2022-07-13 20:26 2298

LIMACORPORATE AND ORTHOFIX MEDICAL ANNOUNCE PARTNERSHIP TO PROVIDE SOLUTION FOR PATIENTS WITH HIGH HIP DISLOCATION FOR THE US MARKET

VILLANOVA, Italy, July 13, 2022 /PRNewswire/ -- Limacorporate S.p.A., a global orthopedic company focused on digital innovation and patient-tailored hardware, and Orthofix Medical Inc, a global medical device company with a spine and orthopedics focus, today announced a licensing partnership for ...

2022-07-13 20:10 2356

Glenmark Pharmaceuticals and SaNOtize Announce Peer Reviewed Publication of Its Phase 3 Clinical Trials on SaNOtize's Novel Nitric Oxide Nasal Spray for COVID-19 in Lancet Journal

MUMBAI, India and VANCOUVER, BC, July 13, 2022 /PRNewswire/ -- Glenmark Pharmaceuticals Limited (Glenmark), an innovation-driven, global pharmaceutical company and SaNOtize Research and Development Corp, today announced thatThe Lancet Regional Health Southeast Asia (TLRHSEA) – peer reviewed, high...

2022-07-13 20:06 2559

Brii Biosciences Appoints Dr. Susannah Cantrell as Chief Business Officer

Strategic executive hire adds to Company's global leadership team and positions the Company for continued growth DURHAM, N.C.and BEIJING, July 13, 2022 /PRNewswire/ -- Brii Biosciences Limited  ("Brii Bio" or the "Company", stock code: 2137.HK) a multi-national...

2022-07-13 19:00 2227

AbbVie Employees in Asia Volunteer in Annual Week of Possibilities to Support 2,266 Members of the Community

* Employees in Asia joined the global efforts to make a difference in local communities.  * Employees across 8 locations in Asia contributed a total of 1,870 service hours, supporting 2,266 people.  * The teams across the region organized 18 voluntary programs, in partnership with 25 organi...

2022-07-13 16:10 2736

THE MAENE-VINOLY CONCERT GRAND

A unique 21st Century evolution of the grand piano NEW YORK, July 13, 2022 /PRNewswire/ -- On July 19, 2022, celebrated pianist Kirill Gerstein's performance at the Verbier Festival, which will be broadcast live on Medici.tv, will mark the public debut of the Maene-Viñoly Concert Grand Piano. T...

2022-07-13 15:00 2442

YPO Elects Rafi Demirjian 2022-2023 YPO Chairman

NEW YORK, July 13, 2022 /PRNewswire/ -- YPO, the global leadership community of more than 30,000 chief executives in 142 countries, announces the election of Rafi Demirjian to YPO's highest elected office, chairman of the YPO Board of Directors. Demirjian, whose term began on 1 July 2022, is the ...

2022-07-13 15:00 1946

Subang Jaya Medical Centre Applauded by Frost & Sullivan for Its Leadership Position in the Malaysian Hospital Industry

SJMC is well positioned to drive the private hospital space into its next growth phase, capturing market share and sustaining its leadership in the coming years. SAN ANTONIO, July 13, 2022 /PRNewswire/ -- Recently, Frost & Sullivan researched the Malaysian hospital industry and, based on its ana...

2022-07-13 12:12 1830
1 ... 180181182183184185186 ... 553